Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase-or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

1. Milanés-Guisado, Y.
2. Gutiérrez-Valencia, A.
3. Munõz-Pichardo, J.M.
4. Rivero, A.
5. Trujillo-Rodriguez, M.
6. Ruiz-Mateos, E.
7. Espinosa, N.
8. Roca-Oporto, C.
9. Viciana, P.
10. López-Cortés, L.F.